Arcus, Bristol-Myers, and R1 RCM are Citi’s top stocks in healthcare

seekingalpha2023-12-23

The health care sector (NYSEARCA:XLV) was upgraded to market weight from underweight by Citi Research, as earnings are expected to move higher, according to its U.S. Equity Strategy report on the ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment